These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9265937

  • 21. Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children.
    Karamanlioglu B, Turan A, Memis D, Süt N.
    Eur J Anaesthesiol; 2003 Oct; 20(10):831-5. PubMed ID: 14580054
    [Abstract] [Full Text] [Related]

  • 22. A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatin-related nausea and vomiting.
    Fauser AA, Pizzocaro G, Schueller J, Khayat D, Wilkinson P.
    Support Care Cancer; 2000 Jan; 8(1):49-54. PubMed ID: 10650898
    [Abstract] [Full Text] [Related]

  • 23. A randomized, double-blind, dose-response study of ondansetron in the prevention of postoperative nausea and vomiting.
    Dershwitz M, Conant JA, Chang Y, Rosow CE, Connors PM.
    J Clin Anesth; 1998 Jun; 10(4):314-20. PubMed ID: 9667348
    [Abstract] [Full Text] [Related]

  • 24. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
    Sukhani R, Pappas AL, Lurie J, Hotaling AJ, Park A, Fluder E.
    Anesth Analg; 2002 Nov; 95(5):1230-5, table of contents. PubMed ID: 12401599
    [Abstract] [Full Text] [Related]

  • 25. Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial?
    Tang J, Chen X, White PF, Wender RH, Ma H, Sloninsky A, Naruse R, Kariger R, Webb T, Zaentz A.
    Anesthesiology; 2003 Feb; 98(2):293-8. PubMed ID: 12552184
    [Abstract] [Full Text] [Related]

  • 26. Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery.
    Balfour JA, Goa KL.
    Drugs; 1997 Aug; 54(2):273-98. PubMed ID: 9257083
    [Abstract] [Full Text] [Related]

  • 27. Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting.
    Meyer TA, Roberson CR, Rajab MH, Davis J, McLeskey CH.
    Anesth Analg; 2005 Feb; 100(2):373-377. PubMed ID: 15673860
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study Group.
    Philip BK, McLeskey CH, Chelly JE, McKenzie R, Kovac AL, Diemunsch P, DuBois DM.
    J Clin Anesth; 2000 Feb; 12(1):1-8. PubMed ID: 10773500
    [Abstract] [Full Text] [Related]

  • 30. [Dolasetron, droperidol and a combination of both in prevention of postoperative nausea and vomiting after extracapsular cataract extraction under general anesthesia].
    Eberhart LH, Lindenthal M, Seeling W, Gäckle H, Georgieff M.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):345-9. PubMed ID: 10429772
    [Abstract] [Full Text] [Related]

  • 31. Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin.
    Kris MG, Grunberg SM, Gralla RJ, Baltzer L, Zaretsky SA, Lifsey D, Tyson LB, Schmidt L, Hahne WF.
    J Clin Oncol; 1994 May; 12(5):1045-9. PubMed ID: 8164028
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Droperidol/ondansetron combination controls nausea and vomiting after tubal banding.
    McKenzie R, Uy NT, Riley TJ, Hamilton DL.
    Anesth Analg; 1996 Dec; 83(6):1218-22. PubMed ID: 8942589
    [Abstract] [Full Text] [Related]

  • 34. [Prevention of post-operative nausea and vomiting. Randomised comparison of dolasetron versus dolasetron plus dexamethasone].
    Piper SN, Triem JG, Röhm KD, Kranke P, Maleck WH, Boldt J.
    Anaesthesist; 2003 Feb; 52(2):120-6. PubMed ID: 12624696
    [Abstract] [Full Text] [Related]

  • 35. Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study.
    Argiriadou H, Papaziogas B, Pavlidis T, Parlapani A, Georgiou M, Papagiannopoulou P, Papaziogas T.
    Surg Endosc; 2002 Jul; 16(7):1087-90. PubMed ID: 12165828
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ondansetron prevents postoperative emesis in male outpatients. S3A-379 Study Group.
    Kovac AL, Pearman MH, Khalil SN, Scuderi PE, Joslyn AF, Prillaman BA, Cox F.
    J Clin Anesth; 1996 Dec; 8(8):644-51. PubMed ID: 8982892
    [Abstract] [Full Text] [Related]

  • 39. Oral dolasetron mesilate (MDL 73,147EF) for the control of emesis during fractionated total-body irradiation and high-dose cyclophosphamide in patients undergoing allogeneic bone marrow transplantation.
    Fauser AA, Russ W, Bischoff M.
    Support Care Cancer; 1997 May; 5(3):219-22. PubMed ID: 9176968
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.